CFO4Life Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,786
| Closed | -$837K | – | 227 |
|
|
2024
Q2 | $837K | Buy |
1,786
+12
| +0.7% | +$5.63K | 0.16% | 75 |
|
|
2024
Q1 | $742K | Sell |
1,774
-102
| -5% | -$42.6K | 0.13% | 88 |
|
|
2023
Q4 | $763K | Sell |
1,876
-95
| -5% | -$38.7K | 0.15% | 81 |
|
|
2023
Q3 | $685K | Sell |
1,971
-42
| -2% | -$14.6K | 0.16% | 76 |
|
|
2023
Q2 | $708K | Buy |
2,013
+106
| +6% | +$37.3K | 0.15% | 74 |
|
|
2023
Q1 | $601K | Buy |
1,907
+28
| +1% | +$8.82K | 0.14% | 86 |
|
|
2022
Q4 | $543K | Buy |
+1,879
| New | +$543K | 0.12% | 100 |
|